What's in Catherine Vandepitte, M.D.'s pipeline?

Catherine Vandepitte, M.D. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Catherine Vandepitte, M.D.'s portfolio?

Top competitors by shared drug class: Huazhong University of Science and Technology, Maimonides Medical Center, Pacira Pharmaceuticals, Inc, The Cleveland Clinic, The Cooper Health System.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/catherine-vandepitte-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Catherine Vandepitte, M.D. — Portfolio Competitive Intelligence Brief

Catherine Vandepitte, M.D. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Liposome bupivacaine	Liposome bupivacaine	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels	Anesthesia / Pain Management

Therapeutic area mix

Anesthesia / Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Huazhong University of Science and Technology · 1 shared drug class
Maimonides Medical Center · 1 shared drug class
Pacira Pharmaceuticals, Inc · 1 shared drug class
The Cleveland Clinic · 1 shared drug class
The Cooper Health System · 1 shared drug class
The University of Texas Health Science Center, Houston · 1 shared drug class
Tianjin Medical University General Hospital · 1 shared drug class
University of California, Davis · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Catherine Vandepitte, M.D.:

Cite this brief

Drug Landscape (2026). Catherine Vandepitte, M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/catherine-vandepitte-m-d. Accessed 2026-05-16.